7775 — Daiken Medical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapNeutral

Annual income statement for Daiken Medical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,862	8,540	9,137	9,750	9,952
Cost of Revenue
Gross Profit	3,359	3,684	3,530	3,982	4,097
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,953	7,391	8,111	8,321	8,441
Operating Profit	909	1,150	1,026	1,429	1,510
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	945	1,151	1,025	1,436	1,508
Provision for Income Taxes
Net Income After Taxes	675	831	712	989	1,098
Net Income Before Extraordinary Items
Net Income	675	831	712	989	1,098
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	675	831	712	989	1,098
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	23.8	29	25.5	34.7	38.2
Dividends per Share